Erasca, Inc. ERAS In Process Research And Development Expense
In Process Research And Development Expense at other companies
Other financials
Where this comes from
Reported directly by Erasca, Inc. in its filing.
Tagged under the XBRL concept eras:InProcessResearchAndDevelopmentExpense.
The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Erasca, Inc.'s in process research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Erasca, Inc.'s in process research and development expense?
- Erasca, Inc. (ERAS) reported in process research and development expense of $150M in Q1 2026.
- What does in process research and development expense mean?
- Represents the portion of research and development costs associated with acquiring or developing intangible assets that have not yet reached technological feasibility. For clinical-stage companies, this reflects the ongoing investment in pipeline assets that do not have an alternative future use. High levels of this expense indicate significant commitment to early-stage innovation and future product development.